We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Craneware Plc | LSE:CRW | London | Ordinary Share | GB00B2425G68 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-80.00 | -3.57% | 2,160.00 | 2,200.00 | 2,250.00 | 2,250.00 | 2,225.00 | 2,250.00 | 75,720 | 16:35:02 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Prepackaged Software | 174.02M | 9.23M | 0.2626 | 84.73 | 782.26M |
TIDMCRW
RNS Number : 0538H
Craneware plc
08 March 2018
Craneware plc
("Craneware", "the Group" or the "Company")
Director's Exercise of Options
8 March 2018 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that Keith Neilson, CEO of the Company, yesterday exercised two tranches of options over a total of 29,081 ordinary shares of 1p each ("Ordinary Shares"). The first tranche of 18,248 Ordinary Shares was exercised at a price of 335 pence per Ordinary Share. The second tranche of 10,833 Ordinary Shares was exercised at a price of 400 pence per Ordinary Share.
Following the exercise of these options, Mr Neilson holds 3,377,799 Ordinary Shares in the capital of the Company, representing 12.8% per cent. of the Company's issued share capital.
The exercise of options has been fulfilled via the issue of Ordinary Shares held in the Company's Employee Benefit Trust. There is therefore no change to the Company's issued share capital.
For further information, please contact:
Craneware Peel Hunt Alma plc +44 (0)131 +44 (0)20 +44 (0)208 550 3100 7418 8900 004 4218 Keith Neilson, Dan Webster Caroline Forde CEO Craig Preston, George Sellar Hilary Buchanan CFO Nicole McDougall Robyn Fisher
About Craneware
Craneware (AIM: CRW.L) is the market leader in software and supporting services that help healthcare providers improve margins so they can invest in quality patient outcomes. The Company's flagship solution, Chargemaster Toolkit(R), has earned the KLAS No.1 ranking in Revenue Cycle - Chargemaster Management since 2006 and is part of Craneware's value cycle management suite, which includes patient engagement, charge capture and pricing, claims analysis, revenue recovery and retention, and cost analytics solutions.
Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta, Boston and Pittsburgh employing over 250 staff.
Learn more at www.craneware.com.
Appendix 1
1 Details of the person discharging managerial responsibilities/person closely associated ---- ------------------------------------------------------------------ a) Name: Keith Neilson ---- ---------------------------------- ------------------------------ 2 Reason for the notification ---- ------------------------------------------------------------------ a) Position/Status: Chief Executive Officer ---- ---------------------------------- ------------------------------ b) Initial Notification/Amendment: Initial Notification ---- ---------------------------------- ------------------------------ 3 Details of the issuer, emission allowance market participation, auction platform, auctioneer or auction monitor ---- ------------------------------------------------------------------ a) Name: Craneware plc ---- ---------------------------------- ------------------------------ b) LEI: 213800O2CTJ1YFXNXG05 ---- ---------------------------------- ------------------------------ 4. Details of transaction(s); section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted. ---- ------------------------------------------------------------------ a) Description Ordinary Shares of the financial ISIN GB00B2425G68 instrument: Identification code: ---- ---------------------------------- ------------------------------ b) Nature of the Exercise of Options transaction: ---- ---------------------------------- ------------------------------ c) Price(s) and Price(s) Volume(s) volume(s): ---- ---------------------------------- -------------- -------------- GBP3.35 18,248 GBP4.00 10,833 ------------------------------------------------------ -------------- d) Aggregated Price(s) Volume(s) price(s) and volume(s): ---- ---------------------------------- -------------- -------------- GBP3.592 29,081 ------------------------------------------------------ -------------- e) Date of the 7 March 2018 Transaction: ---- ---------------------------------- ------------------------------ f) Place of the Outside of a trading venue Transaction: ---- ---------------------------------- ------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEAADPEESPEEF
(END) Dow Jones Newswires
March 08, 2018 02:01 ET (07:01 GMT)
1 Year Craneware Chart |
1 Month Craneware Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions